1-(3-Bromo-5-methylphenyl)pyrrolidine

Catalog No. :
ACXWDS641
CAS No. :
1199773-07-3
Molecular Formula :
C11H14BrN
Molecular Weight :
240.14

IUPAC Name:1-(3-bromo-5-methylphenyl)pyrrolidine

1-(3-Bromo-5-methylphenyl)pyrrolidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$137.00Login to see priceInquiryInquiry
5g98%$370.00Login to see priceInquiryInquiry
10g98%$643.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Bromo-5-methylphenyl)pyrrolidine
IUPAC Name1-(3-bromo-5-methylphenyl)pyrrolidine
MDL No.B180046
Molecular FormulaC11H14BrN
Molecular Weight240.14
SMILESCC1=CC(Br)=CC(N2CCCC2)=C1
InChI KeyXCHZZMSGUDXAGD-UHFFFAOYSA-N
Synonym1-(3-Bromo-5-methylphenyl)pyrrolidine | 1199773-07-3 | 3-Bromo-5-pyrrolidinotoluene | SCHEMBL18278244 | DTXSID70682094 | ZXB77307 | MFCD13195737 | AKOS015834175 | BS-20015 | Pyrrolidine, 1-(3-bromo-5-methylphenyl)- | CS-0207823 | A892383
CAS No.1199773-07-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXWDS641 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNZHB157 route compound structure diagram
    ACNZHB157110-52-1 In Stock
  2. Plus
  3. ACHVSB713 route compound structure diagram
    ACHVSB71374586-53-1 In Stock
  4. Then
  5. ACXWDS641 route product structure diagram
    ACXWDS6411199773-07-3
Inquiry

2. ACXWDS641 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVRIM241 route compound structure diagram
    ACVRIM2411611-92-3 In Stock
  4. Then
  5. ACXWDS641 route product structure diagram
    ACXWDS6411199773-07-3
Inquiry

Comments (0)